Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ORLADEYO 150 MG CAPSULAS DURAS

Approved

STANDARD

ORLADEYO 150 MG CAPSULAS DURAS

Biocryst Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 30, 2022
Approval ID: b7459e1f7acb8e05
Company: Biocryst Ireland Limited
Type: Standard

Approval Details

Approval Id: b7459e1f7acb8e05
Drug Cima Aemps Name: ORLADEYO 150 MG CAPSULAS DURAS
Register Number: 1211544001
Holder Company Name: Biocryst Ireland Limited
Marketing Company Name: Biocryst Ireland Limited
Holder Company Detail Path: /organization/biocryst-ireland-ltd
Marketing Company Detail Path: /organization/biocryst-ireland-ltd
Authorization Date: 2022-11-30
Dosage Form: CÁPSULA DURA
Dose: 150 MG
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Biocryst Ireland Limited
Company Detail Path: /organization/biocryst-ireland-ltd

Company Information

Pharmaceutical Company Name: BioCryst Ireland Ltd.
Country Name: Ireland

Active Ingredients

BEROTRALSTAT DIHIDROCLORURO

172,41 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 30, 2022

Approval ID

b7459e1f7acb8e05

Type

Standard

Back to CIMA-AEMPS Approvals

ORLADEYO 150 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details